Continue reading here:
3Daughters Secures $4.7 Million in Oversubscribed Seed Round
Author Archives: Danzig
Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia…
Fortrea Appoints Robert Parks as Chief Accounting Officer
See the original post here:
Fortrea Appoints Robert Parks as Chief Accounting Officer
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
Here is the original post:
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment
Clene Announces Plans to Submit Briefing Book to the U.S. Food and Drug Administration in Connection with Granted Type C Interaction to Obtain FDA…
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Continue reading here:
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Virbac: Termination of the liquidity contract
Here is the original post:
Virbac: Termination of the liquidity contract
Oxurion provides clarification on the agenda of the extraordinary general shareholders’ meeting to be held on 24 July 2024
Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory…
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
See the original post here:
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Spectral Medical Inc. Announces Change to Auditor
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
Go here to read the rest:
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024